Operating Grant: Winter 2009 Priority Announcement (Myotonic Dystrophy – Rachel Fund) – Funding Decisions Notification (March 2009 Competition: 200903RAC)
(Alternate Title: Operating Grant-Pr An: Myotonic Dystrophy (Rachel Fund))The Canadian Institutes of Health Research (CIHR) is pleased to announce the results of the Operating Grant: Winter 2009 Priority Announcement (Myotonic Dystrophy – Rachel Fund) competition.
Funding Opportunity Summary
The objectives of the "Operating Grant: Winter 2009 Priority Announcement (Myotonic Dystrophy – Rachel Fund)" were to:
- Fund highly ranked applications that were determined to be relevant to the research priorities of Muscular Dystrophy Canada and CIHR-IMHA;
- To support research on therapeutics (pharmacological, cell based, genetic) and/or translational aspects that pertain directly to Myotonic dystrophy; and
- To support research on the genetic, cellular or biochemical processes involved in Myotonic dystrophy.
Funding Competition Summary
A total of 3 applications were received of which 2 were approved for funding.
Contact Information
For further information about this competition, please contact:
Karen Chaundy
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: 613-954-5396
Fax: 613-954-1800
Email: karen.chaundy@cihr-irsc.gc.ca
For further information about this initiative and the objectives of this funding opportunity please contact:
Elizabeth Stirling
Associate Scientific Director, IMHA
Canadian Institutes of Health Research
Telephone: 613-957-8678
Fax: 613-954-1800
Email: liz.stirling@cihr-irsc.gc.ca
Funding Decisions Data Report
Access the "Operating Grant-Pr An: Myotonic Dystrophy (Rachel Fund)" funding decisions data report.